Redsense Medical AB (REDS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Redsense Medical AB (REDS) has a cash flow conversion efficiency ratio of -0.053x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.92 Million ≈ $-206.08K USD) by net assets (Skr35.92 Million ≈ $3.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See REDS net asset quality index to measure how much of total assets are equity-financed.
Redsense Medical AB - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Redsense Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Redsense Medical AB's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Redsense Medical AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Redsense Medical AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Trive Property Group Bhd
KLSE:0118
|
-0.003x |
|
Lanakam S.A
AT:LANAC
|
0.007x |
|
Damodar Industries Limited
NSE:DAMODARIND
|
0.146x |
|
Raj Oil Mills Limited
NSE:ROML
|
1.915x |
|
Intelicanna Ltd
TA:INTL
|
-0.023x |
|
Euro Manganese Inc
AU:EMN
|
3.412x |
|
Siamraj Public Company Limited
BK:SR
|
0.026x |
|
Manhattan Corporation Limited
F:32U
|
-0.016x |
Annual Cash Flow Conversion Efficiency for Redsense Medical AB (2020–2024)
The table below shows the annual cash flow conversion efficiency of Redsense Medical AB from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see Redsense Medical AB market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr39.59 Million ≈ $4.26 Million |
Skr-8.23 Million ≈ $-885.57K |
-0.208x | +4.97% |
| 2023-12-31 | Skr23.09 Million ≈ $2.49 Million |
Skr-5.05 Million ≈ $-543.68K |
-0.219x | +39.29% |
| 2022-12-31 | Skr27.15 Million ≈ $2.92 Million |
Skr-9.78 Million ≈ $-1.05 Million |
-0.360x | -10.55% |
| 2021-12-31 | Skr37.49 Million ≈ $4.03 Million |
Skr-12.22 Million ≈ $-1.32 Million |
-0.326x | -238.47% |
| 2020-12-31 | Skr73.20 Million ≈ $7.88 Million |
Skr17.23 Million ≈ $1.85 Million |
0.235x | -- |
About Redsense Medical AB
Redsense Medical AB (publ) develops a monitoring system to detect sign of a blood leak using patented fiber optic technology primarily in Europe, Canada, and the United States. The company offers Redsense System, a product that is used for monitoring and alarming in the case of blood leakage during hemodialysis treatment; and Redsense venous sensor patch, a noninvasive patch that consists of an o… Read more